부산대학교 도서관

57 New Eng. L. Rev. F. 1 (2022-2023) / New England Law Review Forum, Vol. 57, pp. 1-26

Levin, Myron J.; Ginde, Adit A.; Schmid, D. Scott; Lang, Nancy; Canniff, Jennifer; Schwartz, Robert S.; Weinberg, Adriana

In Vaccine 2 April 2024 42(9):2278-2281

Guay, Kevin P.; Ke, Haiping; Canniff, Nathan P.; George, Gracie T.; Eyles, Stephen J.; Mariappan, Malaiyalam; Contessa, Joseph N.; Gershenson, Anne; Gierasch, Lila M.; Hebert, Daniel N.

In Molecular Cell 21 December 2023 83(24):4524-4537

Canniff, Nathan P.; Graham, Jill B.; Guay, Kevin P.; Lubicki, Daniel A.; Eyles, Stephen J.; Rauch, Jennifer N.; Hebert, Daniel N.

In Journal of Biological Chemistry December 2023 299(12)

Seong Yeon Park; Myron J. Levin; Jennifer Canniff; Michael Johnson; D. Scott Schmid; Adriana Weinberg

npj Vaccines, Vol 7, Iss 1, Pp 1-7 (2022)

Ferreira, Adriana; Golner, Amanda; Hovind, Laura; Weinberg, Adriana ; Muresan, Petronella; Laimon, Lauren; Pelton, Stephen I; Goldblatt, David; Canniff, Jennifer; Zimmer, Bonnie; Bone, Frederic; Newton, Lassallete; Fenton, Terence; Kiely, James; Johnson, Michael J; Joao, Esau C; Santos, Breno R; Machado, Elizabeth S; Pinto, Jorge A; Chakhtoura, Nahida; Duarte, Geraldo; Mussi-Pinhata, Marisa M

In The Lancet HIV July 2021 8(7):e408-e419

El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut.; Meador CB; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Qiu X; Department of Medicine, Yale School of Medicine, New Haven, Connecticut.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Davidsohn MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lakshminarayanan G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; McClure HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Fortunato B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Li R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Banwait MK; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eli and Edythe L. Broad Institute, Cambridge, Massachusetts.; Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hung YP; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Piotrowska Z; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eli and Edythe L. Broad Institute, Cambridge, Massachusetts.; Hata AN; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eli and Edythe L. Broad Institute, Cambridge, Massachusetts.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

El Zarif T; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Garinet S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Davidsohn MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sahgal P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Fortunato B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Nassar AH; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Abou Alaiwi S; Section of Cardiology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Bakouny Z; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Lakshminarayanan G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lyons K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Matar S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Ali A; Department of Medicine, University of Minnesota Masonic Cancer Center, Minneapolis, MN, USA.; Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cordeiro P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; El Ahmar N; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Laimon YN; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.; Shah V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freeman D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; O'Toole J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hwang J; Department of Medicine, University of Minnesota Masonic Cancer Center, Minneapolis, MN, USA.; Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Xie W; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Viswanathan SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Braun DA; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: toni_choueiri@dfci.harvard.edu.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: matthew_freedman@dfci.harvard.edu.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. Electronic address: sylvan_baca@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Levin, Myron J.; Cai, Guang-Yun; Lee, Katherine S.; Rouphael, Nadine G.; Mehta, Aneesh K.; Canniff, Jennifer; Mulligan, Mark J.; Weinberg, Adriana

The Journal of Infectious Diseases, 2018 Apr 01. 217(7), 1055-1059.

Canniff, Julie G.; Shank, Melody J.